Precision

Precision company information, Employees & Contact Information

Explore related pages

Related company profiles:

Precision is an integrated strategy and marketing agency. Powered by data, we bring world-class experts in each of our service areas to conceive, develop, and run campaigns that help our clients seize opportunities and solve their biggest challenges. Whether it is elevating a brand, shaping a narrative, defining a reputation, navigating a crisis, or persuading and mobilizing an audience, we don’t just break through. We break new ground. Precision’s origin story is in the intense spotlight of national political campaigns, where our founders learned that relentless innovation and the expert use of data are the difference between winning and losing. That tireless, nimble and strategic approach has always been our North Star. Our industry-celebrated talent brings diverse perspectives and deep subject matter expertise. With a unique blend of talent from across both public and private sectors, from creative directors to data and targeting experts to digital marketers, campaign managers and crisis leaders, we have the insights and understanding to navigate complex landscapes with strategic clarity, and the experience and drive to produce results. We believe that data and research are the cornerstone of any successful strategy. But we don’t just collect data: we curate and transform it into actionable intelligence, custom-built strategies, and inspired creative campaigns that break through. From Fortune 500s to sports and entertainment, grassroots campaigns and leading advocacy organizations, we’ve helped nearly every kind of organization deepen their impact, improve their standing, and grow their bottom line. Reach out if we could do the same for you.
Looking for a particular Precision employee's phone or email?

Precision Questions

News

D. Boral Capital Acted as Exclusive Placement Agent to Humacyte (Nasdaq: HUMA) in Connection with its $60,000,000 Registered Direct Offering - Newswire.com

D. Boral Capital Acted as Exclusive Placement Agent to Humacyte (Nasdaq: HUMA) in Connection with its $60,000,000 Registered Direct Offering Newswire.com

Humacyte, Inc. Reports Zero Infections and High Patency Rates for Symvess in Military Medicine Journal Publication on Wartime Vascular Trauma Treatment - Quiver Quantitative

Humacyte, Inc. Reports Zero Infections and High Patency Rates for Symvess in Military Medicine Journal Publication on Wartime Vascular Trauma Treatment Quiver Quantitative

$60M Gross Proceeds: Humacyte Prices Oversubscribed Direct Offering of 28.4M Shares & Warrants - Stock Titan

$60M Gross Proceeds: Humacyte Prices Oversubscribed Direct Offering of 28.4M Shares & Warrants Stock Titan

May at MoMI: new season of Open Worlds programs launches - I Love NY

May at MoMI: new season of Open Worlds programs launches I Love NY

Humacyte, Inc. to Release First Quarter 2025 Financial Results on May 13, 2025 - Nasdaq

Humacyte, Inc. to Release First Quarter 2025 Financial Results on May 13, 2025 Nasdaq

Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus - Yahoo Finance

Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus Yahoo Finance

87.1% patency in 17 patients — Humacyte's Symvess shows zero infections, amputations or deaths - Stock Titan

87.1% patency in 17 patients — Humacyte's Symvess shows zero infections, amputations or deaths Stock Titan

Museum of the Moving Image to open major exhibition “Mission: Impossible—Story and Spectacle” - I Love NY

Museum of the Moving Image to open major exhibition “Mission: Impossible—Story and Spectacle” I Love NY

Humacyte, Inc. Presents Positive Results from Phase 3 Clinical Trial of Acellular Tissue Engineered Vessel at Society for Vascular Surgery Vascular Annual Meeting - Quiver Quantitative

Humacyte, Inc. Presents Positive Results from Phase 3 Clinical Trial of Acellular Tissue Engineered Vessel at Society for Vascular Surgery Vascular Annual Meeting Quiver Quantitative

Humacyte Announces Economic Value of Symvess in Budget Impact Model Publication - Nasdaq

Humacyte Announces Economic Value of Symvess in Budget Impact Model Publication Nasdaq

Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025 - Yahoo Finance

Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025 Yahoo Finance

Breakthrough in Organ Engineering: Humacyte Patents Revolutionary Bioengineered Esophagus Technology - Stock Titan

Breakthrough in Organ Engineering: Humacyte Patents Revolutionary Bioengineered Esophagus Technology Stock Titan

Humacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics Agency - Yahoo Finance

Humacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics Agency Yahoo Finance

Humacyte Q2 Earnings: Bioengineered Tissue Pioneer Reveals Latest Financial Performance - Stock Titan

Humacyte Q2 Earnings: Bioengineered Tissue Pioneer Reveals Latest Financial Performance Stock Titan

Humacyte Breaks Into Military Healthcare: FDA-Approved Symvess Now Serving 200,000 Military Personnel - Stock Titan

Humacyte Breaks Into Military Healthcare: FDA-Approved Symvess Now Serving 200,000 Military Personnel Stock Titan

Breakthrough in Heart Surgery: Humacyte's Bioengineered Vessel Maintains Perfect Blood Flow for 6 Months - Stock Titan

Breakthrough in Heart Surgery: Humacyte's Bioengineered Vessel Maintains Perfect Blood Flow for 6 Months Stock Titan

Humacyte Secures Major Funding Round: TD Cowen, Barclays Back SYMVESS Commercialization - Stock Titan

Humacyte Secures Major Funding Round: TD Cowen, Barclays Back SYMVESS Commercialization Stock Titan

Humacyte Secures $50M Funding: Major Push for SYMVESS Commercialization - Stock Titan

Humacyte Secures $50M Funding: Major Push for SYMVESS Commercialization Stock Titan

New Study: Humacyte's Symvess Cuts Trauma Center Costs by $33,000 Per Patient - Stock Titan

New Study: Humacyte's Symvess Cuts Trauma Center Costs by $33,000 Per Patient Stock Titan

Masters of Precision: Strategies for Milling and Trimming Composites Event Details - CompositesWorld

Masters of Precision: Strategies for Milling and Trimming Composites Event Details CompositesWorld

Mike Spahn appointed first non-founding partner at Precision Strategies - PRWeek

Mike Spahn appointed first non-founding partner at Precision Strategies PRWeek

Precision Strategies - PRovoke Media

Precision Strategies PRovoke Media

Pluristyx Announces License Agreement with Humacyte to Develop BioVascular Pancreas using iPSCs - Business Wire

Pluristyx Announces License Agreement with Humacyte to Develop BioVascular Pancreas using iPSCs Business Wire

Humacyte to Participate at Upcoming Investor Conferences in September - Stock Titan

Humacyte to Participate at Upcoming Investor Conferences in September Stock Titan

Humacyte, Inc. Reports First Quarter 2025 Financial Results and Market Launch of Symvess™ for Vascular Trauma Treatment - Nasdaq

Humacyte, Inc. Reports First Quarter 2025 Financial Results and Market Launch of Symvess™ for Vascular Trauma Treatment Nasdaq

Scoop: Top Democratic PR firm moving to unionize - Axios

Scoop: Top Democratic PR firm moving to unionize Axios

Humacyte Q2 Earnings: Military Hospitals Join 277-Strong Network as Product Sales Hit Record High - Stock Titan

Humacyte Q2 Earnings: Military Hospitals Join 277-Strong Network as Product Sales Hit Record High Stock Titan

Smithsonian’s National Portrait Gallery Hosts Star-Studded 2019 American Portrait Gala - Smithsonian Institution

Smithsonian’s National Portrait Gallery Hosts Star-Studded 2019 American Portrait Gala Smithsonian Institution

Humacyte Announces First Quarter 2025 Financial Results and Provides Business Update - Stock Titan

Humacyte Announces First Quarter 2025 Financial Results and Provides Business Update Stock Titan

Unjust Legal Marathon Ends for Varsity Blues Defendant John Wilson; Sets the Record Straight In and Outside the Courtroom - PR Newswire

Unjust Legal Marathon Ends for Varsity Blues Defendant John Wilson; Sets the Record Straight In and Outside the Courtroom PR Newswire

Cointreau Unveils “Love Letter” Encouraging Consumers to Support Their Favorite Local Restaurants and Bars in First-Ever Big Game Campaign - Business Wire

Cointreau Unveils “Love Letter” Encouraging Consumers to Support Their Favorite Local Restaurants and Bars in First-Ever Big Game Campaign Business Wire

Gilead Sciences COMPASS Initiative™ Awards Over $2.3M to 40 Organizations Fighting HIV in the South - PR Newswire

Gilead Sciences COMPASS Initiative™ Awards Over $2.3M to 40 Organizations Fighting HIV in the South PR Newswire

Advantia Health Expands Nationally With Acquisition of Heartland Women's Healthcare - PR Newswire

Advantia Health Expands Nationally With Acquisition of Heartland Women's Healthcare PR Newswire

Beto O’Rourke Hires Former Obama Aide as Campaign Manager (Published 2019) - The New York Times

Beto O’Rourke Hires Former Obama Aide as Campaign Manager (Published 2019) The New York Times

At U.S. - Africa Business Forum, Ghana's Fidelity Bank Chooses IBM to Drive Transformation Agenda - PR Newswire

At U.S. - Africa Business Forum, Ghana's Fidelity Bank Chooses IBM to Drive Transformation Agenda PR Newswire

Top Precision Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant